Medical University Of Graz
Verified site
Graz, Austria
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
Long‑term use of Proton Pump Inhibitors can disturb the normal balance of bacteria in the gut, a condition known as dysbiosis. The study focuses on adults who have this imbalance and examines whether adding a probiotic powder containing bacillus clausii (commercially called Enterogermina) can improve digestive comfort compared with a harmless inactive powder.
The purpose of the study is to see if the probiotic can reduce gastrointestinal symptoms in people taking these acid‑reducing medicines. Participants are randomly assigned to receive either the probiotic or the inactive powder, without knowing which they are taking. The study lasts about seven weeks, during which participants take the assigned powder each day and complete simple symptom questionnaires at several visits.
Throughout the trial, researchers keep track of any side effects or health changes, and participants may be asked to provide small samples of stool or saliva for laboratory analysis. All information is collected confidentially to evaluate the safety and possible benefit of the probiotic treatment.
The trial runs in 8 steps – from screening to follow-up. Each step says what happens and what the team monitors.
5 criteria
10 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Graz, Austria
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not yet recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
Enterogermina is an oral powder that contains live spores of the friendly bacteria Bacillus clausii. It is taken by mouth and is intended to add helpful microbes to the gut. In this study the product is being tested to see if it can improve digestive symptoms that can appear after long‑term use of proton‑pump inhibitor medicines, which may disturb the normal balance of gut bacteria. By restoring a healthier mix of gut microbes, the trial aims to find out whether participants feel less discomfort such as bloating, gas, or irregular bowel movements.
This medication is a white oral powder that is mixed with water and taken by mouth. It contains spores of the probiotic bacterium Bacillus clausii and is an approved product listed under the antidiarrheal microorganisms class (ATC A07FA). It is used to help restore a healthy balance of gut bacteria and to reduce diarrhea or dysbiosis, especially after long‑term use of proton‑pump inhibitors. The spores survive the stomach’s acid, reach the intestine, and then grow to support normal bacteria and limit harmful microbes.
This is an inert powder that looks the same as the active product and is also mixed with water and taken by mouth. It contains no active ingredients and is used only as a control in the clinical trial. It has no therapeutic purpose and does not affect the body. It is classified simply as a placebo for study comparisons.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.